Table: begin end state 1 5 non-cytoplasmic 6 26 transmembrane 27 40 cytoplasmic 41 62 transmembrane 63 65 non-cytoplasmic 66 93 transmembrane 94 126 cytoplasmic 127 150 transmembrane 151 161 non-cytoplasmic 162 184 transmembrane 185 191 cytoplasmic 192 210 transmembrane 211 229 non-cytoplasmic 230 250 transmembrane 251 274 cytoplasmic 275 297 transmembrane 298 324 non-cytoplasmic 325 349 transmembrane 350 370 cytoplasmic 371 391 transmembrane 392 401 non-cytoplasmic 402 422 transmembrane 423 428 cytoplasmic 429 447 transmembrane 448 453 non-cytoplasmic 454 474 transmembrane 475 494 cytoplasmic
Input: >GFF3017 FitnessBrowser__psRCH2:GFF3017 MNVSTPTLITFVIYIAAMILIGFIAYRATKNFSDYILGGRSLGSFVTALSAGASDMSGWL LMGLPGAIFVAGLSESWIAIGLIVGAWLNWLFVAGRLRVHTEHNHNALTLPDYFSHRFED ESRMLRIFSALVILVFFTIYCASGVVAGARLFESTFGMPYEYALWVGAAATILYVFIGGF LAVSWTDTVQATLMIFALLVTPVFVILALGDMGTAMATIEAQNPANFDMFRGLSFVAIVS LLAWGLGYFGQPHILVRFMAADSIKTIPNARRIGMTWMILTLAGAVAVGFLGIAYFADHP EQAGAVSQNGERVFMELVKILFNPWVAGIILSGVLAAVMSTLSAQLLVSSSALTQDFYKA MLRKNASQTELVWVGRGMVLLIALIAIGIASNPDSKVLGLVSYAWAGFGAAFGPVVLISL LWKRMTRNGALVGMLVGAVTVVVWKEFIGLGLYEIIPGFILASIAIFVVSKLGAEPAPSI VKRFEEADADYHAG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server